Table 1 Patient- and tumor characteristics
Patients completed all study parts | n = 42 |
|---|---|
Age years (mean, range) | 63 (35–89) |
Tumor size mm (mean, range) | 21 (6–33) |
Positive nodal status | 17 (41%) |
Tumor grade (NHG) | |
I | 9 (21%) |
II | 17 (41%) |
III | 16 (38%) |
Mitotic index | |
1 | 23 (55%) |
2 | 5 (12%) |
3 | 14 (33%) |
ER (n = 30) | |
Positive | 27 (90%) |
Negative | 3 (10%) |
PR (n = 30) | |
Positive | 24(80%) |
Negative | 6 (20%) |
HER2 (n = 29) | |
0 | 7 (24%) |
1+ | 10 (34%) |
2+ | 7 (24%) |
3+ | 5 (17%) |
Ki67 index (n = 26) | |
Low | 15 (58%) |
High | 11 (42%) |
HMGCR (n = 38) | |
Positive | 24 (63%) |
Negative | 14 (37%) |